This page shows the latest Committee for Medicinal Products for Human Use news and features for those working in and with pharma, biotech and healthcare.
The ADC has been recommended with doxorubicin, vinblastine and dacarbazine. Takeda has announced that the European Medicines Agency’s human medicines committee has recommended Adcetris (brentuximab vedotin) as part of a ... The Committee for Medicinal
Gilead Sciences has announced that its COVID-19 treatment Veklury (remdesivir) has been recommended by the European Medicines Agency’s human medicines committee for use in patients with mild-to-severe ... The Committee for Medicinal Products for Human
Almirall has announced that its IL-13 inhibitor lebrikizumab has been recommended by the European Medicines Agency’s human medicines committee to treat moderate-to-severe atopic dermatitis. ... The Committee for Medicinal Products for Human Use (CHMP)
Pfizer and BioNTech’s Omicron XBB.1.5-adapted monovalent COVID-19 vaccine has been recommended by the European Medicines Agency’s human medicines committee for individuals aged six months and ... older. The Committee for Medicinal Products for Human
Roche’s spinal muscular atrophy (SMA) therapy has been recommended by the European Medicines Agency’s human medicines committee for use in infants aged under two months. ... The Committee for Medicinal Products for Human Use (CHMP) has recommended
Janssen, a Johnson &Johnson company, has announced that its bi-specific antibody, Talvey (talquetamab), has been recommended by the European Medicines Agency’s (EMA) human medicines committee for use in certain ... The Committee for Medicinal Products
More from news
Approximately 8 fully matching, plus 447 partially matching documents found.
Most members of the EMA’s Committee for Medicinal Products for Human Use supported approval on the strength of the analysis but there was some pushback. ... Recognising that, the United Kingdom has sought to position its relatively standardised, single
Early signs are looking good: Novartis’ Kymriah (tisagenlecleucel) and Gilead/Kite’s Yescarta (axicabtagene ciloleucel) secured positive opinions from EMA's Committee for Medicinal Products for Human Use (CHMP) in June ... So far, 37 sessions of
After long discussions between politicians in the respective countries about its safety, and after the CHMP's (EMA Committee for Medicinal Products for Human Use) recommendation, the European Commission finally made ... A promotional claim is not allowed
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
The European Medicines Agency (EMA) has appointed France's Dr Pierre Demolis as vice-chair of the Committee for Medicinal Products for Human Use (CHMP). ... In his new role, he will work with chair Dr Tomas Salmonson of Sweden to head the CHMP, which
On their election, Mentzer and van den Berg thanked outgoing chair Daniel Brasseur, who has left the PDCO to become a member of the European Medicines Agency's Committee for Medicinal ... Products for Human Use (CHMP).
Its objective is to assess and monitor safety issues for human medicines, giving recommendations for consideration by the Committee for Medicinal Products for Human Use (CHMP). ... Its current chair is Dr June Raine of the UK's Medicines and Healthcare
Will serve a three-year term on EMA's scientific advisory committee. The EMA's Committee for Medicinal Products for Human Use (CHMP) has elected Dr Ian Hudson to serve as ... Dr Hudson has been a member of the scientific advisory committee since 2004 and
He replaces Eric Abadie who retired in April. Tomas Salmonson has been appointed chair of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). ... EMA's Committee for Proprietary Medicinal Products (CPMP) from 1999
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
No results were found
Wallace Health is a healthcare and medical content agency with a successful track record of delivering web content, content marketing...